Techno Blender
Digitally Yours.
Browsing Tag

Analgesics

Magnesium Supplements Could Protect Liver From Acetaminophen

Magnesium supplements might be able to blunt a well-known side effect of the painkiller acetaminophen, new research suggests. The study found evidence in lab animals that oral magnesium can prevent acetaminophen-related liver damage by affecting the gut microbiome. More research will be needed to confirm this potential protective benefit, however.Zillow Says You’ll Buy Your Next House With… AI? | AI UnlockedAcetaminophen, either taken alone or in combination with other drugs, is one of the most widely used medications in…

Hedge Funds Seek to Cut Off $1 Billion Meant for Opioid Victims

Drugmaker Mallinckrodt is talking to hedge funds about filing for bankruptcy and avoiding payments intended to help people addicted to opioids. Drugmaker Mallinckrodt is talking to hedge funds about filing for bankruptcy and avoiding payments intended to help people addicted to opioids. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All…

Mallinckrodt in Talks to Cut Opioid Settlement by Up to $1 Billion

Mallinckrodt, the financially troubled pharmaceutical company, is in discussions with a compensation trust for opioid victims as it seeks to potentially reduce the amount of settlement payments by as much as $1 billion, according to people familiar with the matter.  The generic drugmaker exited bankruptcy in 2022 with a $1.7 billion settlement agreement with state and local governments and private plaintiffs who alleged the company played a role in fueling the opioid crisis. It paid $450 million upon emergence…

Pharmaceutical Giants Set $19 Billion Opioid Settlement as States Debate How to Spend It

HealthTeva, Allergan, CVS and Walgreens say enough states agreed to final agreements, adding to the billions flowing to communities HealthTeva, Allergan, CVS and Walgreens say enough states agreed to final agreements, adding to the billions flowing to communities FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their…

Telemedicine Startups Wary of Regulatory Shift in War on Opioid Addiction

Telemedicine companies are facing a regulatory shift that many entrepreneurs say would undercut their ability to quickly prescribe medication that helps prevent opioid overdoses. During the Covid-19 pandemic, telehealth companies benefited from a waiver of the requirement that patients be seen in-person before receiving a telemedicine prescription for buprenorphine, a controlled substance used to treat opioid addiction.  The... Telemedicine companies are facing a regulatory shift that many…

McKinsey Consulted VA While Advising Opioid Makers to Target Agency for Sales

Since at least 2009, McKinsey & Co. has been a consultant to the U.S. Department of Veterans Affairs, the federal agency that oversees healthcare for millions of retired military service members. During part of that time, the consulting giant also advised some of the world’s biggest opioid producers to target the agency for sales of their products, according to newly released documents. The firm advised opioid companies including Purdue Pharma LP and Endo International PLC on how to increase sales…

Narcan Maker Gets Fast-Tracked for Over-the-Counter Nasal Spray

Emergent BioSolutions Inc., maker of Narcan, a nasal-spray form of naloxone, said Tuesday that the U.S. Food and Drug Administration fast-tracked an application it submitted for an over-the-counter version of its widely used opioid-reversal nasal spray. The company said it had been working on the application for several months. Emergent said the FDA’s priority review gives the drug an expected approval date of March 29, 2023, putting it first in line for approval ahead of competitors that have…

Naloxone Startup Pursues FDA Approval for Over-the-Counter Swab

A startup vying to produce one of the first over-the-counter overdose-reversal medications said it had submitted results to the Food and Drug Administration showing that its drug works more quickly than prescription-only versions. The randomized trial of 60 healthy volunteers evaluated naloxone absorption from Pocket Naloxone Corp.’s nasal swab versus a 4 milligram nasal-spray delivery and found 74% higher exposure 2.5 minutes after dosing and 19% higher exposure at 5 minutes. Naloxone…

CVS to Pay $5 Billion to Settle Opioid Lawsuits

CVS Health Corp. CVS -0.08% has agreed to pay about $5 billion in a landmark settlement that the company says would resolve all remaining opioid-crisis lawsuits brought by states, cities and other governments. The largest U.S. drugstore company is the first pharmacy chain to reach a settlement in the collection of lawsuits brought by governments and Native American tribes blaming CVS and rival pharmacies for helping fuel the nation’s opioid epidemic.  Under the proposed…